Your browser doesn't support javascript.
loading
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Kolodziejczak, Anna S; Guerrini-Rousseau, Lea; Planchon, Julien Masliah; Ecker, Jonas; Selt, Florian; Mynarek, Martin; Obrecht, Denise; Sill, Martin; Autry, Robert J; Stutheit-Zhao, Eric; Hirsch, Steffen; Amouyal, Elsa; Dufour, Christelle; Ayrault, Olivier; Torrejon, Jacob; Waszak, Sebastian M; Ramaswamy, Vijay; Pentikainen, Virve; Demir, Haci Ahmet; Clifford, Steven C; Schwalbe, Ed C; Massimi, Luca; Snuderl, Matija; Galbraith, Kristyn; Karajannis, Matthias A; Hill, Katherine; Li, Bryan K; Walsh, Mike; White, Christine L; Redmond, Shelagh; Loizos, Loizou; Jakob, Marcus; Kordes, Uwe R; Schmid, Irene; Hauer, Julia; Blattmann, Claudia; Filippidou, Maria; Piccolo, Gianluca; Scheurlen, Wolfram; Farrag, Ahmed; Grund, Kerstin; Sutter, Christian; Pietsch, Torsten; Frank, Stephan; Schewe, Denis M; Malkin, David; Ben-Arush, Myriam; Sehested, Astrid; Wong, Tai-Tong; Wu, Kuo-Sheng.
Affiliation
  • Kolodziejczak AS; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Guerrini-Rousseau L; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Planchon JM; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Ecker J; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
  • Selt F; Molecular Predictors and New Targets in Oncology, Inserm U981 Team "Genomics and Oncogenesis of pediatric Brain Tumors," Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Mynarek M; Department of Diagnostic and Theranostic Medicine, Somatic Genetics Unit, Institut Curie, Paris-Science Lettres University, Paris, France.
  • Obrecht D; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Sill M; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Autry RJ; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Stutheit-Zhao E; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hirsch S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Amouyal E; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Dufour C; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Ayrault O; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
  • Torrejon J; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Waszak SM; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ramaswamy V; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pentikainen V; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Demir HA; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Clifford SC; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Schwalbe EC; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Massimi L; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Snuderl M; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Galbraith K; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Karajannis MA; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Hill K; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Li BK; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Walsh M; SIREDO Pediatric Oncology Center, Institut Curie, Paris-Science Lettres University, Paris, France.
  • White CL; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
  • Redmond S; Molecular Predictors and New Targets in Oncology, Inserm U981 Team "Genomics and Oncogenesis of pediatric Brain Tumors," Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Loizos L; Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.
  • Jakob M; Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.
  • Kordes UR; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Schmid I; Department of Neurology, University of California, San Francisco, CA, USA.
  • Hauer J; Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Blattmann C; Division of Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
  • Filippidou M; Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Piccolo G; Department of Pediatric Hematology-Oncology, Private Memorial Ankara Hospital, Ankara, Turkey.
  • Scheurlen W; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.
  • Farrag A; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.
  • Grund K; Applied Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.
  • Sutter C; Pediatric Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University Medical School, Rome, Italy.
  • Pietsch T; Department of Pathology, New York University Langone Health, New York City, NY, USA.
  • Frank S; Department of Pathology, New York University Langone Health, New York City, NY, USA.
  • Schewe DM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Malkin D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Ben-Arush M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Sehested A; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Wong TT; Victorian Clinical Genetics Services, Parkville, Australia.
  • Wu KS; Hudson Institute of Medical Research, Clayton, Australia.
Neuro Oncol ; 25(12): 2273-2286, 2023 12 08.
Article in En | MEDLINE | ID: mdl-37379234
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Li-Fraumeni Syndrome / Medulloblastoma Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cerebellar Neoplasms / Li-Fraumeni Syndrome / Medulloblastoma Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2023 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido